Ferraro, Daniela A.
Lehner, Fabienne
Becker, Anton S.
Kranzbühler, Benedikt
Kudura, Ken
Mebert, Iliana
Messerli, Michael
Hermanns, Thomas
Eberli, Daniel
Burger, Irene A. http://orcid.org/0000-0001-8029-8692
Funding for this research was provided by:
Iten-Kohaut Foundation
Sick-legat
Article History
Received: 22 May 2020
Accepted: 27 September 2020
First Online: 19 October 2020
Compliance with ethical standards
:
: IAB has received research grants and speaker honorarium from GE Healthcare, research grants from Swiss Life, and speaker honorarium from Bayer Health Care and Astellas Pharma AG. MM received speaker fees from GE Healthcare. TH holds an advisory function for MSD and Bayer. AO declares an advisory role (compensated, institutional) for ‘Astra Zeneca, Astellas, Bayer, Janssen, Molecular Partners, MSD, Pfizer, Roche, Sanofi Aventis; research support (institutional) from TEVA, Janssen; travel support from Astellas, Bayer, Janssen, Sanofi Aventis and speakers bureau (compensated, institutional) from Bayer, Astellas. Authors DAF, FL, ASB, BK, KK, IM and DE declare no conflict of interest. The Department of Nuclear Medicine holds an institutional Research Contract with GE Healthcare.
: The local ethics committee approved the study protocol and all patients gave a general written informed consent for retrospective use of their data (BASEC Nr. 2018–01284).
: Not applicable.